Tiger Brokers

BUZZ-Guangzhou Innogen jumps most in 10 weeks on Veterinary Drug Application

Reuters
Feb 05
BUZZ-Guangzhou Innogen jumps most in 10 weeks on Veterinary Drug Application

** Shares of Guangzhou Innogen Pharmaceutical Group 2591.HK jump 20.1% to HK$31, on track for the biggest one-day pct rise since November 24

** Stock hits its highest level since January 30, on course to snap four consecutive sessions of decline; second-biggest pct gainer in the Hang Seng Composite Index on healthcare .HSCIH, which slips 1%

** China-based pharmaceutical products developer says Investigational New Veterinary Drug application for core product Efsubaglutide Alfa for treatment of companion animal diabetes has been accepted by China's Ministry of Agriculture and Rural Affairs

** Says Phase I clinical trials are expected to commence in the first quarter of 2026

** YTD, stock down 4.8%, benchmark Hang Seng Index .HSI up 3.4%

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10